pharmacopeia

Molybdenum

GET
/api/v1/drug/molybdenum

Mechanism of action

Sourced from openFDA

Mechanism-of-action class: Enzyme Interactions.

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
486 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Diarrhoea336.8%
  2. 2Pain336.8%
  3. 3Headache306.2%
  4. 4Fatigue296.0%
  5. 5Nausea275.6%
  6. 6Arthralgia265.3%
  7. 7Dizziness255.1%
  8. 8Pain In Extremity214.3%
  9. 9Asthenia183.7%
  10. 10Abdominal Pain Upper173.5%
  11. 11Eye Pain173.5%
  12. 12Fall173.5%
  13. 13Gait Disturbance173.5%
  14. 14Muscle Spasms173.5%
  15. 15Dyspnoea163.3%

Literature

View JSON

Recent PubMed references pinned to Molybdenum as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 42 ClinicalTrials.gov registrations naming Molybdenum as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Molybdenum work?
Mechanism-of-action class: Enzyme Interactions.
What class of drug is Molybdenum?
Molybdenum is classified as Enzyme Interactions, Cellular Activity Alteration.
Note. Data for molybdenum is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients